These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Comparative study in heart failure. Which beta blocker saves more life time?]. MMW Fortschr Med; 2003 Oct 02; 145(40):52. PubMed ID: 14603606 [No Abstract] [Full Text] [Related]
6. [For the first time beta blockers are in direct comparison With carvedilol weak hearts beat longer]. MMW Fortschr Med; 2003 Jul 10; 145(27-28):60. PubMed ID: 14587195 [No Abstract] [Full Text] [Related]
10. [Drug therapy of chronic heart failure: when are beta receptor blockers indicated?]. vom Dahl J, Schotten U, Sasse A. Dtsch Med Wochenschr; 1999 Sep 24; 124 Suppl 2():S48-53. PubMed ID: 10535047 [No Abstract] [Full Text] [Related]
11. Commentary on the Carvedilol or Metoprolol European Trial (COMET). Poole-Wilson PA. Am J Cardiol; 2004 May 06; 93(9A):40B-2B. PubMed ID: 15144936 [Abstract] [Full Text] [Related]
13. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial. Kveiborg B, Major-Petersen A, Christiansen B, Torp-Pedersen C. Vasc Health Risk Manag; 2007 May 06; 3(1):31-7. PubMed ID: 17583173 [Abstract] [Full Text] [Related]
14. [Beta blockers for therapy of chronic heart failure]. Murakami T. Nihon Naika Gakkai Zasshi; 2005 Feb 10; 94(2):248-54. PubMed ID: 15768588 [No Abstract] [Full Text] [Related]
15. Comprehensive adrenergic receptor blockade with carvedilol is superior to beta-1-selective blockade with metoprolol in patients with heart failure: COMET. Cleland JG. Curr Heart Fail Rep; 2004 Jul 10; 1(2):82-8. PubMed ID: 16036030 [Abstract] [Full Text] [Related]